Detection and evaluation of dyslipoproteinemia

Related Experiment Video

Updated: Aug 9, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

¹National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.

Endocrinology and Metabolism Clinics of North America

|October 24, 1998

Abstract:

The National Cholesterol Education Program Adult Treatment Panel II guidelines recommend that all adults 20 years of age and older undergo testing to detect dyslipoproteinemia. Clinical trials have proven conclusively that lowering levels of low-density lipoprotein (LDL) cholesterol reduces coronary heart disease (CHD) incidence and mortality and total mortality in patients with and without CHD. There is persuasive scientific evidence to include young adults, women, and the elderly in the recommendation for cholesterol management. In adult without CHD, testing can begin with measurement of total cholesterol (TC) and high-density lipoprotein (HDL) cholesterol in the nonfasting state, and the results can then be used to determine which individuals require a fasting lipoprotein analysis (total cholesterol, HDL, triglycerides, and estimation of LDL); patients with known CHD should begin with lipoprotein analysis. The level of LDL cholesterol and the presence or absence of other CHD risk factors determine the need for cholesterol-lowering therapy. Patients with known CHD are at highest risk for a CHD event and have the lowest LDL cholesterol goal (100 mg/dL); patients without CHD but with elevated LDL-C (130 mg/dL) and two or more other CHD risk factors are at high risk for developing CHD and have an LDL cholesterol goal of less than 130 mg/dL; patients free of CHD with high LDL cholesterol (160 mg/dL) but fewer than two other risk factors have a lower CHD risk and an LDL cholesterol goal of less than 160 mg/dL. Elevated triglyceride may be a marker for other factors that increase CHD risk. Raising HDL cholesterol, while not proven to be of benefit, is reasonable in patients at high CHD risk.

Insights

Regular cholesterol testing is recommended for adults to detect dyslipoproteinemia. Lowering low-density lipoprotein (LDL) cholesterol significantly reduces coronary heart disease (CHD) risk and mortality.

Area of Science:

Cardiology
Preventive Medicine
Lipidology

Background:

The National Cholesterol Education Program (NCEP) Adult Treatment Panel II guidelines advocate for universal cholesterol screening in adults aged 20 and older.
Dyslipoproteinemia detection is crucial for cardiovascular risk assessment.
Clinical evidence strongly supports the benefits of lowering low-density lipoprotein (LDL) cholesterol in reducing coronary heart disease (CHD) incidence and mortality.

Purpose of the Study:

To summarize current guidelines for dyslipoproteinemia screening and management.
To emphasize the importance of cholesterol management across diverse adult populations, including young adults, women, and the elderly.
To outline risk stratification strategies based on LDL cholesterol levels and the presence of other CHD risk factors.

Main Methods:

Non-fasting total cholesterol (TC) and high-density lipoprotein (HDL) cholesterol measurements for initial screening in adults without CHD.
Fasting lipoprotein analysis (including triglycerides and estimated LDL cholesterol) for individuals requiring further assessment.
Lipoprotein analysis as the initial step for patients with known CHD.

Main Results:

Specific LDL cholesterol goals are defined based on CHD status and the number of risk factors: <100 mg/dL for patients with known CHD, <130 mg/dL for those without CHD but with multiple risk factors, and <160 mg/dL for those with fewer risk factors.
Elevated triglycerides may indicate other CHD risk factors.
While not definitively proven, increasing HDL cholesterol is considered reasonable for high-CHD-risk patients.

Conclusions:

Cholesterol management is essential for all adults, with tailored LDL cholesterol goals based on individual risk profiles.
Early detection and management of dyslipoproteinemia are key to reducing CHD burden.
A comprehensive approach considering LDL, HDL, triglycerides, and overall risk factors is necessary for effective cardiovascular disease prevention.

Read full analysis

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

Related Concept Videos

Lipid Digestion

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Articles linked to this work by shared authors, journal, and citation graph.

Clinical goals and performance measures for cholesterol management in secondary prevention of coronary heart disease.

JAMA·2000

Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program.

Archives of internal medicine·1999

Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey.

Preventive medicine·1999

The National Cholesterol Education Program: progress and prospects.

JAMA·1999

Adults aged 20 and older should have their cholesterol measured.

The American journal of medicine·1997

Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel.

JAMA·1993

See all related articles